0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Central Nervous System Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Alzheimer's-disease - Pipeline Insight, 2025 - Product Thumbnail Image

Alzheimer's-disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
EUR$3,000USDGBP
Dementia With Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Dementia With Diabetes - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
EUR$1,250USDGBP
Hereditary Transthyretin Amyloidosis (hATTR) - Pipeline Insight, 2025 - Product Thumbnail Image

Hereditary Transthyretin Amyloidosis (hATTR) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
EUR$1,250USDGBP
Dopamine D1 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Dopamine D1 Receptor Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Leptomeningeal Disease -Pipeline Insight, 2025 - Product Thumbnail Image

Leptomeningeal Disease -Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Cannabinoid Receptor CB1 Inverse Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Cannabinoid Receptor CB1 Inverse Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Autistic Disorder- Pipeline Insight, 2025 - Product Thumbnail Image

Autistic Disorder- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
EUR$2,000USDGBP
Spasmodic-torticollis - Pipeline Insight, 2025 - Product Thumbnail Image

Spasmodic-torticollis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
EUR$1,250USDGBP
Neisseria Meningitides Meningitis - Pipeline Insight, 2025 - Product Thumbnail Image

Neisseria Meningitides Meningitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Cerebral Amyloid Angiopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Cerebral Amyloid Angiopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
EUR$1,500USDGBP
Spinal Cord Injury - Pipeline Insight, 2025 - Product Thumbnail Image

Spinal Cord Injury - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
EUR$2,000USDGBP
Peripheral Nerve Injuries - Pipeline Insight, 2025 - Product Thumbnail Image

Peripheral Nerve Injuries - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
EUR$1,500USDGBP
Sturge-Weber Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Sturge-Weber Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
EUR$1,250USDGBP
Facioscapulohumeral Muscular Dystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Facioscapulohumeral Muscular Dystrophy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Excessive Daytime Sleepiness - Pipeline Insight, 2025 - Product Thumbnail Image

Excessive Daytime Sleepiness - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Small Fiber Neuropathy - Pipeline Insight, 2025 - Product Thumbnail Image

Small Fiber Neuropathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
EUR$1,250USDGBP
Chronic Traumatic Encephalopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Traumatic Encephalopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Refractory Status Epilepticus - Pipeline Insight, 2025 - Product Thumbnail Image

Refractory Status Epilepticus - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Lou Gehrig's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Lou Gehrig's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
EUR$3,000USDGBP
LRRK2 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

LRRK2 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Loading Indicator

The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products. Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more